USPTO 2015–2025 USPTO PatentsView US Corporation

Vedabio, Inc.

USPTO PatentsView assignee record - 18 granted patents across 3 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

The verdict

According to USPTO PatentsView, Vedabio ranks #16,490 of 50,000 tracked US assignees by granted-patent volume, with 18 patents across 3 technology areas.

#16,490
of 50,000 US assignees by volume
Top 12%
by Innovation Score (51.3/100)
27.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R16490 Β· US Corporation #16,490 Β· 18 grants

GRANTS-MICRO Β· MID-PACK Β· PHOTO-FINISH Β· CPC-NARROW Β· INNOV-PAR Β· CLAIMS-DENSE Β· TYPE-USCORP Β· SPAN-YRS Β· BOOK-RICH

  • GRANTS-MICRO 18 grants
  • MID-PACK #16,490/50,000
  • PHOTO-FINISH Vatbox
  • CPC-NARROW C12N Β· 3 areas
  • INNOV-PAR 51.3/100
  • CLAIMS-DENSE 27.2 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2023–2025 Β· 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Vatbox, Ltd. (Β±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Vedabio

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Vedabio, Inc. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-PAR, CLAIMS-DENSE, TYPE-USCORP, SPAN-YRS, BOOK-RICH. Volume places it #16,490 of 50,000; Innovation Score 51.3/100 sits in the top 12% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Vatbox, Ltd. (Β±0 grants).

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Portfolio overview

Vedabio, Inc. has been granted 18 US utility patents between 2023 and 2025, placing Vedabio, Inc. at #16,490 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 27.2 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Vedabio, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Vedabio sits between Voltronic Power Technology Corp. (18 patents, rank #16,492) and Virco Mfg. Corporation (18 patents, rank #16,500) - the closest US assignees by grant volume. The composite Innovation Score of 51.3/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2023 through 2025, with 18 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Vedabio, Inc.'s 27.2 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 3 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Vedabio's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked β—€

patents

What this shows Vedabio holds 18 patents at rank #16,496, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Vedabio

By rank, the assignees closest to #16,496 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Vedabio's primary technology class.

Vedabio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score Β· 2015–2025

051015 202320242025 3
USPTO utility patent grants by year Β· 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table
Vedabio, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2023 1 5.6%
2024 14 77.8%
2025partial year 3 16.7%

Where it ranks

Overall rank by patents

#16,490

of 50,000 tracked assignees

Innovation Score

51.3 out of 100

View all rankings β†’

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.